SOP for Genomic Data Handling and Biobanking Governance

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-genomic-data-handling-and-biobanking-governance”
},
“headline”: “SOP for Genomic Data Handling and Biobanking Governance”,
“description”: “This SOP defines procedures for handling genomic data and managing biobanks in clinical trials. It ensures compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements while safeguarding subject privacy, data security, and ethical governance of biobanking activities.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Published on 24/12/2025

Standard Operating Procedure for Genomic Data Handling and Biobanking Governance

SOP No.	CR/OPS/126/2025
Supersedes	NA
Page No.	1 of 74
Issue Date	26/08/2025
Effective Date	01/09/2025
Review Date	01/09/2026

Table of Contents

Purpose

The purpose of this SOP is to define standardized procedures for the collection, handling, storage, analysis, and governance of genomic

data and biobanked samples in clinical trials. This ensures regulatory compliance, ethical oversight, subject privacy, and integrity of genetic research data.

Scope

This SOP applies to sponsors, investigators, biobank managers, CROs, laboratory staff, data managers, and regulatory affairs personnel involved in genomic data and biobanking governance. It covers consent, data acquisition, storage, transfer, analysis, quality control, archiving, and inspection readiness.

Responsibilities

Sponsor: Ensures ethical and compliant genomic data collection and biobank governance.
Investigator: Obtains informed consent for genomic studies and sample use.
Biobank Manager: Oversees secure sample storage and access control.
Laboratory Staff: Processes genomic samples under validated procedures.
CRO: Monitors genomic data collection and biobank compliance.
QA: Conducts audits on genomic data handling and governance procedures.
Data Protection Officer: Ensures GDPR/HIPAA compliance for genomic data privacy.

Accountability

The Sponsor’s Genomic Program Lead is accountable for governance of genomic data and biobanking processes. Biobank Managers are accountable for sample integrity and security at storage facilities.

Procedure

1. Informed Consent for Genomic Data
1.1 Obtain subject consent for genomic sample collection and data use.
1.2 Include rights for withdrawal of genomic data.
1.3 Record in Genomic Consent Log (Annexure-1).

2. Sample Collection and Handling
2.1 Collect samples under validated procedures.
2.2 Use anonymization or pseudonymization for identifiers.
2.3 Record in Sample Collection Log (Annexure-2).

3. Biobank Storage and Security
3.1 Store samples in validated biobank facilities with environmental monitoring.
3.2 Control access to authorized personnel only.
3.3 Document in Biobank Storage Log (Annexure-3).

4. Genomic Data Handling
4.1 Process data using validated bioinformatics pipelines.
4.2 Encrypt data during transfer and storage.
4.3 Record in Genomic Data Handling Log (Annexure-4).

5. Data Privacy and Security
5.1 Comply with GDPR, HIPAA, and regional privacy rules.
5.2 Maintain subject confidentiality at all stages.
5.3 Document in Data Privacy Compliance Log (Annexure-5).

6. Quality Assurance
6.1 Perform quality checks on genomic data and biobank records.
6.2 Record in QA Log (Annexure-6).

7. Data Sharing and Transfer
7.1 Share genomic data with regulators/repositories under approved agreements.
7.2 Maintain Data Transfer Log (Annexure-7).

8. Archiving
8.1 Archive genomic data and sample records in TMF and ISF.
8.2 Retain per regulatory timelines (minimum 25 years in EU).

Abbreviations

SOP: Standard Operating Procedure
CRO: Contract Research Organization
QA: Quality Assurance
HIPAA: Health Insurance Portability and Accountability Act
GDPR: General Data Protection Regulation
ISF: Investigator Site File
TMF: Trial Master File
FDA: Food and Drug Administration
EMA: European Medicines Agency
CDSCO: Central Drugs Standard Control Organization
WHO: World Health Organization

Documents

Genomic Consent Log (Annexure-1)
Sample Collection Log (Annexure-2)
Biobank Storage Log (Annexure-3)
Genomic Data Handling Log (Annexure-4)
Data Privacy Compliance Log (Annexure-5)
QA Log (Annexure-6)
Data Transfer Log (Annexure-7)

References

Version: 1.0

Approval Section

Prepared By	Ravi Kumar, Genomic Data Specialist
Checked By	Sunita Reddy, QA Officer
Approved By	Dr. Anil Sharma, Head Clinical Operations

Annexures

Annexure-1: Genomic Consent Log

Date	Subject ID	Consent Obtained	Investigator	Status
01/09/2025	G101	Yes	PI	Signed

Annexure-2: Sample Collection Log

Date	Subject ID	Sample Type	Collected By	Status
02/09/2025	G101	Blood	Lab Staff	Processed

Annexure-3: Biobank Storage Log

Date	Sample ID	Storage Location	Temperature	Status
03/09/2025	SB-101	Freezer-01	-80°C	Stored

Annexure-4: Genomic Data Handling Log

Date	Dataset	Handled By	Activity	Status
04/09/2025	G101-RNA	Data Manager	Processed	Validated

Annexure-5: Data Privacy Compliance Log

Date	System	Privacy Measure	Reviewed By	Status
05/09/2025	Biobank Database	Encryption + Pseudonymization	DPO	Compliant

Annexure-6: QA Log

Date	Activity	Auditor	Outcome
06/09/2025	Biobank Sample Audit	QA Officer	Compliant

Annexure-7: Data Transfer Log

Date	Dataset	Transferred To	Method	Status
07/09/2025	G101-RNA	Regulatory Repository	Secure FTP	Transferred

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
26/08/2025	00	Initial version	New SOP creation	Head Clinical Operations

For more SOPs visit: Pharma SOP